Violeta Zaric

502 total citations
15 papers, 407 citations indexed

About

Violeta Zaric is a scholar working on Molecular Biology, Cognitive Neuroscience and Genetics. According to data from OpenAlex, Violeta Zaric has authored 15 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cognitive Neuroscience and 6 papers in Genetics. Recurrent topics in Violeta Zaric's work include Memory and Neural Mechanisms (5 papers), Virus-based gene therapy research (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Violeta Zaric is often cited by papers focused on Memory and Neural Mechanisms (5 papers), Virus-based gene therapy research (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Violeta Zaric collaborates with scholars based in United States, Ireland and France. Violeta Zaric's co-authors include Alexander J. McDonald, Franco Mascagni, Andrew McDonald, D Weltin, Jean‐Paul Behr, Jay F. Muller, Patrick Erbacher, Dominique Stéphan, Jean-Serge Rémy and Steven J. Gray and has published in prestigious journals such as The Journal of Comparative Neurology, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Violeta Zaric

15 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Violeta Zaric United States 11 221 146 136 117 42 15 407
Eline van Hugte Netherlands 9 175 0.8× 179 1.2× 99 0.7× 69 0.6× 46 1.1× 11 424
Mei Yuan China 6 191 0.9× 153 1.0× 223 1.6× 201 1.7× 19 0.5× 16 458
Esther Yang South Korea 15 231 1.0× 214 1.5× 128 0.9× 94 0.8× 38 0.9× 29 451
Masanari Ohtsuka Japan 9 200 0.9× 268 1.8× 159 1.2× 102 0.9× 14 0.3× 10 504
H. Tagaya Japan 5 120 0.5× 113 0.8× 68 0.5× 80 0.7× 24 0.6× 6 527
Liliya Silayeva United States 6 428 1.9× 333 2.3× 82 0.6× 130 1.1× 46 1.1× 6 666
Klaus Wanisch United Kingdom 9 259 1.2× 195 1.3× 99 0.7× 145 1.2× 24 0.6× 10 518
Mica Y. Bergman United States 5 132 0.6× 131 0.9× 120 0.9× 187 1.6× 38 0.9× 7 380
Noam D. Rudnick United States 9 443 2.0× 129 0.9× 74 0.5× 116 1.0× 45 1.1× 16 764
Gal Hacohen-Kleiman Israel 8 162 0.7× 114 0.8× 93 0.7× 127 1.1× 38 0.9× 12 368

Countries citing papers authored by Violeta Zaric

Since Specialization
Citations

This map shows the geographic impact of Violeta Zaric's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Zaric with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Zaric more than expected).

Fields of papers citing papers by Violeta Zaric

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violeta Zaric. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Zaric. The network helps show where Violeta Zaric may publish in the future.

Co-authorship network of co-authors of Violeta Zaric

This figure shows the co-authorship network connecting the top 25 collaborators of Violeta Zaric. A scholar is included among the top collaborators of Violeta Zaric based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violeta Zaric. Violeta Zaric is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Karumuthil‐Melethil, Subha, Violeta Zaric, Patrick Thompson, et al.. (2021). Investigating Immune Responses to the scAAV9-HEXM Gene Therapy Treatment in Tay–Sachs Disease and Sandhoff Disease Mouse Models. International Journal of Molecular Sciences. 22(13). 6751–6751. 7 indexed citations
2.
Marshall, Michael S., Duc Nguyen, Emily Rue, et al.. (2018). Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe’s Disease after Global Gene Therapy. Molecular Therapy. 26(3). 874–889. 45 indexed citations
3.
Song, Liujiang, et al.. (2018). Serotype survey of AAV gene delivery via subconjunctival injection in mice. Gene Therapy. 25(6). 402–414. 40 indexed citations
4.
Sinnett, Sarah E., Ralph D. Hector, Kamal K.E. Gadalla, et al.. (2017). Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery. Molecular Therapy — Methods & Clinical Development. 5. 106–115. 56 indexed citations
5.
Muller, Jay F., Franco Mascagni, Violeta Zaric, David D. Mott, & Alexander J. McDonald. (2016). Localization of the M2 muscarinic cholinergic receptor in dendrites, cholinergic terminals, and noncholinergic terminals in the rat basolateral amygdala: An ultrastructural analysis. The Journal of Comparative Neurology. 524(12). 2400–2417. 17 indexed citations
6.
McDonald, Alexander J. & Violeta Zaric. (2015). Extrinsic origins of the somatostatin and neuropeptide Y innervation of the rat basolateral amygdala. Neuroscience. 294. 82–100. 18 indexed citations
7.
McDonald, Andrew & Violeta Zaric. (2015). GABAergic somatostatin-immunoreactive neurons in the amygdala project to the entorhinal cortex. Neuroscience. 290. 227–242. 35 indexed citations
8.
Craven, Brian, et al.. (2015). Effect of Genetic Deletion or Pharmacological Antagonism of Tumor Necrosis Factor Alpha on Colitis-associated Carcinogenesis in Mice. Inflammatory Bowel Diseases. 21(3). 485–495. 11 indexed citations
9.
Muller, Jay F., Franco Mascagni, Violeta Zaric, & Alexander J. McDonald. (2013). Muscarinic cholinergic receptor M1 in the rat basolateral amygdala: Ultrastructural localization and synaptic relationships to cholinergic axons. The Journal of Comparative Neurology. 521(8). 1743–1759. 29 indexed citations
10.
11.
Zaric, Violeta, Isabel Rozas, Kevin McMahon, et al.. (2006). N-Glycosyl-thiophene-2-carboxamides: synthesis, structure and effects on the growth of diverse cell types. Carbohydrate Research. 341(10). 1370–1390. 10 indexed citations
12.
13.
Zaric, Violeta, D Weltin, Patrick Erbacher, et al.. (2004). Effective polyethylenimine‐mediated gene transfer into human endothelial cells. The Journal of Gene Medicine. 6(2). 176–184. 63 indexed citations
14.
Weltin, D, et al.. (2000). Gene therapy for coronary disease.. PubMed. 61(1). 85–90. 2 indexed citations
15.
Weltin, D, et al.. (2000). Angiogenèse: de la physiologie à la thérapeutique. Réanimation Urgences. 9(7). 534–544. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eline van Hugte Breakdown of academic impact, for papers by Mei Yuan Breakdown of academic impact, for papers by Esther Yang Breakdown of academic impact, for papers by Masanari Ohtsuka Breakdown of academic impact, for papers by H. Tagaya Breakdown of academic impact, for papers by Liliya Silayeva Breakdown of academic impact, for papers by Klaus Wanisch Breakdown of academic impact, for papers by Mica Y. Bergman Breakdown of academic impact, for papers by Noam D. Rudnick Breakdown of academic impact, for papers by Gal Hacohen-Kleiman
Rankless by CCL
2026